Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A rheumatic heart disease and drug technology, applied in the field of drugs for the treatment of rheumatic heart disease, can solve problems such as mitral regurgitation and increased risk of surgery, and achieve a high cure rate
Inactive Publication Date: 2016-06-08
林南平
View PDF4 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0008] ① Mitral regurgitation
Patients with atrial fibrillation, pulmonary hypertension, systemic embolism and functional tricuspid regurgitation should also undergo surgery, but the risk of surgery increases
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0065] Weigh: 22 grams of alum root, 12 grams of General Mao, 9 grams of pituitary bark, 7 grams of aster, 12 grams of double flower sheath, 10 grams of straight calyx scutellaria, 12 grams of wild orchid; add 8 times the amount of water, fry Boil for 1.5 hours, filter; add 6 times the amount of water to the filter residue, decoct for 1 hour, filter; combine the filtrates, concentrate to 120 grams, that is, a decoction that meets the daily dosage of normal adults.
[0066] For the treatment of rheumatic heart disease. Take it orally once a day.
Embodiment 2
[0068] Weighing: 22 grams of alum root, 12 grams of General Mao, 9 grams of pituitary bark, 7 grams of aster, 12 grams of double flower sheath, 10 grams of Scutellaria baicalensis, 12 grams of wild orchid; add 10 times the amount of water, fry Boil for 2 hours, filter; add 8 times the amount of water to the filter residue, decoct for 1.5 hours, filter; combine the filtrates, concentrate, dry, and pack to obtain a powder that meets the daily dosage of normal adults.
[0069] For the treatment of rheumatic heart disease. Take it orally, take it twice a day in the morning and evening.
Embodiment 3
[0071] Weigh: 22 grams of alum root, 12 grams of General Mao, 9 grams of Pittosporum skin, 7 grams of aster, 12 grams of double flower sheath, 10 grams of Scutellaria baicalensis, 12 grams of wild orchid; add 6 times the amount of water, fry Boil for 3 times, decoct for 1 hour each time, combine the decoction liquid, concentrate, dry, and pack into capsule shells to obtain capsules that meet the daily dosage of normal adults.
[0072] For the treatment of rheumatic heart disease. Take it orally, and take it three times a day in the morning, afternoon and evening.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicine for treating rheumatic heart disease. The medicine is prepared from the following medicinal raw materials in parts by weight: 22 parts of caudate sweetleaf roots, 12 parts of radix euphorbiae, 9 parts of cortex erythrinae, 7 parts of radix asteris, 12 parts of macrosolen bibracteolatus, 10 parts of scutellaria orthocalyx and 12 parts of herba artemisiae annuae. According to the medicine, caudate sweetleaf roots have the effects of clearing heat, inducing diuresis, cooling blood, stopping bleeding, expelling wind and relieving pain; radix euphorbiae has the effects of stopping bleeding by astringency, relieving dysentery and killing parasites; cortex erythrinae has the effects of dispelling wind, drying dampness, relaxing muscles and tendons, removing obstructionfrom meridians, killing parasites and relieving itching; radix asteris has the effects of moistening lung, descending qi, eliminating phlegm and relieving cough; macrosolen bibracteolatus has the effect of removing wind-dampness; scutellaria orthocalyx has the effects of purging internal fire, relieving asthma, removing toxicity and diminishing swelling; herba artemisiae annuae has the effects of clearing heat, inducing diuresis and removing jaundice. The medicinal materials are combined to achieve the effects of promoting blood circulation to remove blood stasis, calming heart, tonifying lung, warming yang, inducing diuresis, tonifying qi and consolidating depletion. The medicine can be used for safely and effectively treating rheumatic heart disease.
Description
technical field [0001] The invention relates to a traditional Chinese medicine, in particular to a medicine for treating rheumatic heart disease. Background technique [0002] Rheumatic heart disease, referred to as rheumatic heart disease for short, is a common connective tissue disease, which refers to the heart valve disease caused by the activity of rheumatic fever and involving the heart valve. Manifested as mitral valve, tricuspid valve, aortic valve in one or more valve stenosis and (or) insufficiency. Clinically, stenosis or regurgitation often exist at the same time, but one kind is often the main one. In the early stage of the disease, there are often no obvious symptoms, but in the later stage, symptoms of cardiac decompensation such as palpitation, shortness of breath, fatigue, cough, lower extremity edema, and pink frothy sputum are manifested. For the pathogenesis of rheumatic fever, modern medicine once had streptococcal toxin theory, allergy theory, virus i...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more